Clinical Trial Update: Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of PN20 in adults with primary immune thrombocytopenia (ITP). The sponsor is Chongqing Peg-Bio Biopharm Co.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• PN20

Snippet

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 1 | Status: RECRUITING